Fn14/TRAIL fusion proteins

Fusion proteins which act on the TWEAK and TRAIL signaling axes are provided. The proteins are useful in the treatment or amelioration of autoimmune diseases, particularly multiple sclerosis, as well as other diseases such as alloimmune diseases and cancer.

Saved in:
Bibliographic Details
Main Authors TYKOCINSKI MARK L, RAZMARA MARJANEH
Format Patent
LanguageEnglish
Published 18.10.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Fusion proteins which act on the TWEAK and TRAIL signaling axes are provided. The proteins are useful in the treatment or amelioration of autoimmune diseases, particularly multiple sclerosis, as well as other diseases such as alloimmune diseases and cancer.
Bibliography:Application Number: US20090494680